Author

valerie byrnes

MEASURING THE DISSEMINATION OF GASTROENTEROLOGY & HEPATOLOGY RESEARCH- AN ALTERNATIVE METRIC ANALYSIS OF MOST INFLUENTIAL RESEARCH ARTICLES
MEASURING THE DISSEMINATION OF GASTROENTEROLOGY & HEPATOLOGY RESEARCH- AN ALTERNATIVE METRIC ANALYSIS OF MOST INFLUENTIAL RESEARCH ARTICLES

valerie byrnes  et al.

'TO BLOCK' OR 'NOT TO BLOCK': THE QUESTION OF ANGIOTENSIN RECEPTOR BLOCKER (ARBS) DISCONTINUATION IN COELIAC DISEASE
'TO BLOCK' OR 'NOT TO BLOCK': THE QUESTION OF ANGIOTENSIN RECEPTOR BLOCKER (ARBS) DISCONTINUATION IN COELIAC DISEASE

valerie byrnes  et al.

POOR CORRELATION BETWEEN ANTI-TTG IGG AND MUCOSAL RECOVERY IN THE IGA-DEFICIENT COELIAC
POOR CORRELATION BETWEEN ANTI-TTG IGG AND MUCOSAL RECOVERY IN THE IGA-DEFICIENT COELIAC

valerie byrnes  et al.

UTILITY OF FLOW CYTOMETRY IN THE PREDICTION OF OUTCOME OF REFRACTORY COELIAC DISEASE TYPE II (RCD II)
UTILITY OF FLOW CYTOMETRY IN THE PREDICTION OF OUTCOME OF REFRACTORY COELIAC DISEASE TYPE II (RCD II)

valerie byrnes  et al.

COELIAC DIAGNOSIS IN OLDER ADULTS: DOES AGE REALLY MATTER?
COELIAC DIAGNOSIS IN OLDER ADULTS: DOES AGE REALLY MATTER?

valerie byrnes  et al.

DRUG INDUCED ENTEROPATHY IN COELIAC DISEASE: A MULTIVARIATE ANALYSIS OF COMMONLY PRESCRIBED MEDICATIONS
DRUG INDUCED ENTEROPATHY IN COELIAC DISEASE: A MULTIVARIATE ANALYSIS OF COMMONLY PRESCRIBED MEDICATIONS

valerie byrnes  et al.

MUCOSAL RECOVERY IN COELIAC DISEASE: AN ACHIEVABLE TARGET OR AN UNREALISTIC GOAL?
MUCOSAL RECOVERY IN COELIAC DISEASE: AN ACHIEVABLE TARGET OR AN UNREALISTIC GOAL?

valerie byrnes  et al.

THE PERSISTENCE OF A HIGH INCIDENCE OF COELIAC DISEASE IN THE WEST OF IRELAND; 50 YEARS ON
THE PERSISTENCE OF A HIGH INCIDENCE OF COELIAC DISEASE IN THE WEST OF IRELAND; 50 YEARS ON

valerie byrnes  et al.

SHOULD DUODENAL BIOPSY STILL BE A PREREQUISITE FOR THE DIAGNOSIS OF COELIAC DISEASE IN ADULTS? AN ANALYSIS OF THE DIAGNOSTIC UTILITY OF SEROLOGY
SHOULD DUODENAL BIOPSY STILL BE A PREREQUISITE FOR THE DIAGNOSIS OF COELIAC DISEASE IN ADULTS? AN ANALYSIS OF THE DIAGNOSTIC UTILITY OF SEROLOGY

valerie byrnes  et al.

ORAL INHIBITOR OF TISSUE TRANSGLUTAMINASE PREVENTS MUCOSAL DAMAGE IN CELIAC PATIENTS UNDERGOING GLUTEN CHALLENGE
ORAL INHIBITOR OF TISSUE TRANSGLUTAMINASE PREVENTS MUCOSAL DAMAGE IN CELIAC PATIENTS UNDERGOING GLUTEN CHALLENGE

valerie byrnes  et al.

Item 1 - 10 / 10
1